Claims Surface That Trump Misled on Cannabis Rescheduling Opposition

The federal landscape for cannabis is shifting rapidly following President Trump’s recent move to reschedule marijuana. While Trump promoted medical cannabis as a vital alternative to opioids, political friction is heating up. Some GOP senators claim the administration ignored internal opposition, while a group of Republican attorneys general are actively fighting the reclassification. Despite this pushback, the move is sparking fresh legalization momentum in states like Pennsylvania and Tennessee, and even giving a second wind to federal marijuana banking reform.

For the average enthusiast, this high-level political maneuvering is more than just talk; it’s the engine driving better access and safety. Federal rescheduling could finally break the banking stalemate, making it easier for local shops to operate without being cash-only targets. While some states like Ohio are seeing attempts to roll back progress, the overall trend is leaning toward a more regulated, accessible market. This matters because it paves the way for lower costs, more consistent product testing, and the eventual end of the "prohibition-style" hurdles that still plague the community.